Xavier Hebuterne

Xavier Hebuterne

Auto-generated profile, based on publicly available information

Xavier Hebuterne

Gastro-entérologie et Nutrition clinique, CHU de Nice et Université Côte d'Azur, Nice, France

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Clinical Nutrition
Verified
Journal Article
Closed access
AFAlastair Forbes
Alastair Forbes
JEJohanna Escher
Johanna Escher
XHXavier Hébuterne
Xavier Hébuterne
SKStanislaw Klek
Stanislaw Klek
ŽKŽeljko Krznarić
Željko Krznarić
SBStephan C. Bischoff
Stephan C. Bischoff

13 January 2023 in Clinical Nutrition
Verified
Journal Article
Closed access
SBStephan C. Bischoff
Stephan C. Bischoff
PBPalle Bager
Palle Bager
JEJohanna Escher
Johanna Escher
AFAlastair Forbes
Alastair Forbes
XHXavier Hébuterne
Xavier Hébuterne
Arved WeimannArved Weimann
Arved Weimann

1 June 2014 in Best Practice & Research Clinical Gastroenterology
Verified
Journal Article
Closed access
OAOphélie Antunes
Ophélie Antunes
JFJérôme Filippi
Jérôme Filippi
XHXavier Hébuterne
Xavier Hébuterne
Laurent Peyrin-birouletLaurent Peyrin-biroulet
Laurent Peyrin-biroulet

30 September 2014 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
XHXavier Hebuterne
Xavier Hebuterne
JFJerome Filippi
Jerome Filippi
Stéphane M. SchneiderStéphane M. Schneider
Stéphane M. Schneider
Seventy five percent of hospitalized patients with Crohn’s disease suffer from malnutrition. One third of Crohn’s disease patients have a body mass index below 20. Sixty percent of Crohn’s disease patients have sarcopenia. However some inflammatory bowel disease (IBD) patients are obese or suffer from sarcopenic-obesity. IBD patients have many vitamin and nutrient deficiencies, which can lead to important consequences such as hyperhomocysteinemia, which is associated with a higher risk of thromboembolic disease. Nutritional deficiencies in IBD patients are the result of insufficient intake, malabsorption and protein-losing enteropathy as well as metabolic disturbances directly induced by the chronic disease and its treatments, in particular corticosteroids. Screening for nutritional deficiencies in chronic disease patients is warranted. Managing the deficiencies involves simple nutritional guidelines, vitamin supplements, and nutritional support in the worst cases.

30 April 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SNStephane NANCEY
Stephane NANCEY
XHXavier Hébuterne
Xavier Hébuterne
CGCyrielle Gilletta
Cyrielle Gilletta
EHEvguenia Hacques
Evguenia Hacques
Xavier RoblinXavier Roblin
Xavier Roblin
Background: Corticosteroids used to induce a response in Crohn’s disease (CD) and ulcerative colitis (UC) may cause adverse reactions. The DICE study aimed to quantify and investigate factors associated with their use. Methods: This cross-sectional, non-interventional study conducted in seven countries allowed us to collect data on oral corticosteroid exposure and excessive use (cf. British Society of Gastroenterology) over the past 12 months in adult patients with CD or UC for more than a year. The factors associated with these practices were investigated using marginal logistic models. We present the results from the four participating French expert centers. Results: Corticosteroid exposure over the past 12 months was observed in 20.1% of 324 CD patients and 30.2% of 205 UC patients. Excessive use was reported in 13.3% and 17.1% of patients, respectively. Corticosteroid exposure and excessive use were less frequently observed in CD than in UC (OR: 0.56, p < 0.0001, and 0.69, p = 0.0042). A disease activity assessment at patient’s last visit was the main factor (p < 0.01) associated with the risk of corticosteroid exposure and excessive use in CD (OR: 3.41 and 3.44) and UC (OR: 7.29 and 6.90). Conclusions: Corticosteroid exposure and excessive use continue to be frequently observed in CD and UC in France.

1 January 2000
Verified
Journal Article
Closed access
FLF Longo
F Longo
XHX Hebuterne
X Hebuterne
ATA Tran
A Tran
PSP Staccini
P Staccini
PHP Hastier
P Hastier
PRP Rampal
P Rampal